Italy / Stevanato’s $5 bn valuation; Zolgensma Approval; Sputnik V Manufacturing
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…
Address: via Ribes, 5 – 10010 Colleretto Giacosa (TO),Italy
Tel: +39 0125 561311
Web: http://www.bioindustrypark.eu/
Bioindustry Park Canavese is a science and technology park located in Canavese, near Turin in the north of Italy. The Park promotes and develops research in biotechnologies and life sciences, hosting enterprises of the chemical, pharmaceutical, diagnostic, bioengineering and iformation science fields.
It offers research facilities, scientific and support services, such as technology transfer, patent support, tutoring/mentoring of start-ups and spin-offs.
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…
A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…
In July 2020, Italy became the first country in the world to mandate pharma companies to disclose data surrounding…
Below we present recent news from Italy’s biopharma industry, including the recent acquisition of Stemline…
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US…
Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based…
Prof. Luca G. Guidotti discusses the esteemed positioning of San Raffaele within the global scientific community,…
The division of neuroscience at the San Raffaele Scientific Institute is one of the best worldwide performers in…
Professor Angelo Corti, Director of the Experimental Oncology division of the SRSI, discusses approaches to…
Dr. Paola Pozzi, the head of the Office of Biotechnology Transfer at the San Raffaele Scientific Institute,…
Italy’s traditional family-owned pharmaceutical companies are one of its greatest strengths; but these companies…
Thilo Stadler speaks passionately about Grünenthal’s collaborative partnerships, company goals, and workforce…